Sort
40,608 grants matching “prostate cancer”
THE (CPCA): A COOPERATIVE EFFORT FOR CONDUCTING PROSTATE CANCER-FOCUSED CLINICAL TRIALS
$1,255,244University Of Chicago · · FY2009 · Department of Defense
Multi Source E-Beam kV X-Ray Tube for Image-Guided Radiotheraphy
$1,254,926Douglas P Boyd · Telesecurity Sciences, Inc. · R44 · FY2016 · CA
Center for Interventional Oncology
$1,254,568Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
$1,254,180Dennis Brown · Kintara Therapeutics, Inc. · R44 · FY2023 · CA
Loma Linda University Center for Health Disparities Research
$1,253,971Marino De Leon · Loma Linda University · P20 · FY2014 · MD
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,253,944New York University School Of Medicine · U01 · FY2002 · CA
Nutrition, Metabolism, and Cancer
$1,252,965Regina G Ziegler · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
STRUCTURE FUNCTION AND INHIBITION OF ONECUT2, DRIVER OF PROSTATE CANCER
$1,252,500Cedars-Sinai Medical Center · · FY2025 · Defense Health Agency
RIPK2 AS A THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCERS
$1,252,500The Research Foundation For The State University Of New York · · FY2022 · Defense Health Agency
MECHANISMS AND THERAPEUTIC TARGETING OF NUCLEAR SHAPE INSTABILITY IN LETHAL PROSTATE CANCER
$1,252,500Cedars-Sinai Medical Center · · FY2020 · Defense Health Agency
DRIVERS AND DOWNSTREAM EFFECTORS OF WNT SIGNALING IN LETHAL PROSTATE CANCER
$1,252,396Beth Israel Deaconess Medical Center, Inc. · · FY2020 · Defense Health Agency
NOVEL LINEAGE PLASTICITY INHIBITORS IN PROSTATE CANCER
$1,252,233Cedars-Sinai Medical Center · · FY2022 · Department of the Army
Comprhensive Center of Excellence in Health Disparities
$1,251,750Timothy R Rebbeck · University Of Pennsylvania · P60 · FY2013 · MD
AN IMMUNOTHERANOSTIC ANTIBODY FOR THE DETECTION AND ERADICATION OF METASTATIC PROSTATE CANCER: A PROOF-OF-CONCEPT STUDY IN NONHUMAN PRIMATES
$1,250,847Sloan-Kettering Institute For Cancer Research · · FY2018 · Defense Health Agency
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$1,250,136Lance Yokochi · Pacific Health Research/ Education Inst · N01 · FY2010 · CA
TARGETING ONCOGENOMIC FUNCTION OF N-MYC TO INHIBIT NEUROENDOCRINE PROSTATE CANCER VISCERAL METASTASIS
$1,250,131Duke University · · FY2025 · Defense Health Agency
PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: JOHNS HOPKINS KIMMEL CENCER CENTER SITE
$1,250,015The Johns Hopkins University · · FY2009 · Department of the Army
SPORE IN PROSTATE CANCER
$1,250,001University Of Michigan At Ann Arbor · P50 · FY2002 · CA
Clinical and Translational Science Award
$1,250,000Reza Shaker · Medical College Of Wisconsin · UL1 · FY2021 · TR
Regional Oncology Research Center
$1,250,000Martin D Abeloff · Johns Hopkins University · P30 · FY2006 · CA
LOW-DOSE RADIATION EX VIVO REPROGRAMMED/ACTIVATED CAR T CELLS TARGETING B7-H3 ON PROSTATE CANCER.
$1,249,800The General Hospital Corporation · · FY2021 · Defense Health Agency
Comparative Analysis of Cancer-Associated Genes and Development of a Gene Delive
$1,249,380Vladimir Larionov · Basic Sciences · Z01 · FY2007 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,249,143Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
IMPROVING OUTCOMES IN LETHAL PROSTATE CANCER THROUGH GUIDELINE-CONCORDANT USE OF BONE-MODIFYING AGENTS
$1,248,613Sloan-Kettering Institute For Cancer Research · · FY2021 · Defense Health Agency
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,247,747Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA